# Lightwave Logic, Inc.: overview

LWLG · Nasdaq · CIK 1325964 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lwlg.md) · [Financials](/companies/lwlg/financials.md) · [Filings](/companies/lwlg/filings.md) · [Insiders](/companies/lwlg/insiders.md)

Latest reported revenue: [$32.8k](/filings/0001079973-26-001097.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001079973-26-001097).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [22.9](/filings/0001079973-25-001745.md) | [22.9 d](/filings/0001079973-26-000348.md) | [22.9](/filings/0001553350-26-000087.md) | [25.6](/filings/0001079973-26-001097.md) | [29.2](/filings/0001079973-25-001745.md) | [159 d](/filings/0001079973-26-000348.md) | [29.2](/filings/0001553350-26-000087.md) | [32.8](/filings/0001079973-26-001097.md) |
| Gross margin | % | not reported | not reported | [91.2%](/filings/0001079973-25-000793.md) | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(23115.3%)](/filings/0001079973-25-001745.md) | [(24879.3%) d](/filings/0001079973-26-000348.md) | [(21405.0%)](/filings/0001553350-26-000087.md) | [(19137.6%)](/filings/0001079973-26-001097.md) | [(17757.5%)](/filings/0001079973-25-001745.md) | [(3186.1%) d](/filings/0001079973-26-000348.md) | [(23058.0%)](/filings/0001553350-26-000087.md) | [(22195.2%)](/filings/0001079973-26-001097.md) |
| Net margin | % | [(23131.9%)](/filings/0001079973-25-001745.md) | [(24150.3%) d](/filings/0001079973-26-000348.md) | [(20495.8%)](/filings/0001553350-26-000087.md) | [(19397.1%)](/filings/0001079973-26-001097.md) | [(17488.0%)](/filings/0001079973-25-001745.md) | [(3043.4%) d](/filings/0001079973-26-000348.md) | [(21601.6%)](/filings/0001553350-26-000087.md) | [(20194.2%)](/filings/0001079973-26-001097.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) |
| Free cash flow | $k | [(3,940) d](/filings/0001079973-25-001745.md) | [(3,468) d](/filings/0001079973-26-000348.md) | [(4,344)](/filings/0001553350-26-000087.md) | [(3,810) d](/filings/0001079973-26-001097.md) | [(3,235) d](/filings/0001079973-25-001745.md) | [(3,691) d](/filings/0001079973-26-000348.md) | [(4,512)](/filings/0001553350-26-000087.md) | [(6,889) d](/filings/0001079973-26-001097.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Gross profit: us-gaap:GrossProfit. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [0.0](/filings/0001079973-25-000420.md) | [0.1](/filings/0001079973-26-000348.md) | [0.2](/filings/0001079973-26-000348.md) |
| Gross margin | % | not reported | not reported | [93.8%](/filings/0001079973-25-000420.md) | [92.3%](/filings/0001079973-25-000420.md) | not reported |
| Operating margin | % | not reported | not reported | [(52405.5%)](/filings/0001079973-25-000420.md) | [(24150.6%)](/filings/0001079973-26-000348.md) | [(8765.5%)](/filings/0001079973-26-000348.md) |
| Net margin | % | not reported | not reported | [(51943.2%)](/filings/0001079973-25-000420.md) | [(23571.0%)](/filings/0001079973-26-000348.md) | [(8576.5%)](/filings/0001079973-26-000348.md) |
| Diluted EPS | $ per share | [(0.18)](/filings/0001079973-24-000315.md) | [(0.15)](/filings/0001079973-24-000315.md) | [(0.18)](/filings/0001079973-25-000420.md) | [(0.19)](/filings/0001079973-26-000348.md) | [(0.16)](/filings/0001079973-26-000348.md) |
| Free cash flow | $m | [(11.4)](/filings/0001079973-24-000315.md) | [(11.8)](/filings/0001079973-24-000315.md) | [(15.5)](/filings/0001079973-25-000420.md) | [(17.8)](/filings/0001079973-26-000348.md) | [(15.1)](/filings/0001079973-26-000348.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lwlg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $116.4m | 12,305,846 |  | Added +9,835,780 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $62.0m | 6,551,494 |  | Added +440,563 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $42.0m | 4,443,532 |  | Added +2,740,586 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $41.9m | 4,424,600 |  | Added +1,349,070 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $38.5m | 4,064,111 |  | Added +2,206,472 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $28.9m | 3,057,193 |  | Reduced −2,846,651 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $27.6m | 2,919,015 |  | Added +2,467,665 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $15.1m | 1,594,300 | Put | Added +1,505,100 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $13.1m | 1,385,193 |  | Added +1,052,451 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $12.3m | 1,297,700 | Call | Added +539,000 |

## Recent filings

[All 659 filings](/companies/lwlg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 16:01 ET | [8-K](/filings/0001079973-26-001303.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-001303 |
| 2026-08-14 | 08:00 ET | [10-Q](/filings/0001079973-26-001097.md) | Quarterly report, period 2026-06-30 | 0001079973-26-001097 |
| 2026-07-20 | 09:00 ET | [8-K](/filings/0001079973-26-000955.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000955 |
| 2026-05-27 | 16:01 ET | [8-K](/filings/0001079973-26-000741.md) | 5.07 Shareholder vote results | 0001079973-26-000741 |
| 2026-05-15 | 16:15 ET | [10-Q](/filings/0001553350-26-000087.md) | Quarterly report, period 2026-03-31 | 0001553350-26-000087 |
| 2026-04-21 | 08:02 ET | [8-K](/filings/0001079973-26-000513.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001079973-26-000513 |
| 2026-04-10 | 16:31 ET | [DEF 14A](/filings/0001553350-26-000061.md) | Proxy statement, period 2026-05-21 | 0001553350-26-000061 |
| 2026-03-20 | 16:35 ET | [10-K](/filings/0001079973-26-000348.md) | Annual report, period 2025-12-31 | 0001079973-26-000348 |
| 2026-01-20 | 08:35 ET | [10-Q/A](/filings/0001079973-26-000097.md) | Quarterly report, amended, period 2025-06-30 | 0001079973-26-000097 |
| 2026-01-20 | 08:30 ET | [8-K](/filings/0001079973-26-000096.md) | 4.02 Non-reliance on financial statements | 0001079973-26-000096 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001079973-26-000348.md), filed Mar 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9316212d-0bd3-4359-81ab-b9c5ac464bee)

## About the filer

- CIK: 1325964
- Tickers: LWLG
- Exchange: Nasdaq
- SIC code: 3080 Miscellaneous Plastics Products
- State of incorporation: NV
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:03 ET. No prices; not investment advice.
